Chen Wenbiao, Zhu Peng, Xu Huixuan, Hou Xianliang, Guo Changchun
Central Molecular Laboratory, People's Hospital of Longhua, The Affiliated Hospital of Southern Medical University, Shenzhen 518110, China.
Research Center for Human Tissue and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
J Oncol. 2022 Aug 31;2022:7253876. doi: 10.1155/2022/7253876. eCollection 2022.
The heterogeneity of hepatocellular carcinoma (HCC) is related to immune cell infiltration and genetic aberrations in the tumor microenvironment. This study aimed to identify the novel molecular typing of HCC according to the genetic and immune characteristics, to obtain accurate clinical management of this disease. We performed consensus clustering to divide 424 patients into different immune subgroups and assessed the reproducibility and efficiency in two independent cohorts with 921 patients. The associations between molecular typing and molecular, cellular, and clinical characteristics were investigated by a multidimensional bioinformatics approach. Furthermore, we conducted graph structure learning-based dimensionality reduction to depict the immune landscape to reveal the interrelation between the immune and gene systems in molecular typing. We revealed and validated that HCC patients could be segregated into 5 immune subgroups (IS1-5) and 7 gene modules with significantly different molecular, cellular, and clinical characteristics. IS5 had the worst prognosis and lowest enrichment of immune characteristics and was considered the immune cold type. IS4 had the longest overall survival, high immune activity, and antitumorigenesis, which were defined as the immune hot and antitumorigenesis types. In addition, immune landscape analysis further revealed significant intraclass heterogeneity within each IS, and each IS represented distinct clinical, cellular, and molecular characteristics. Our study provided 5 immune subgroups with distinct clinical, cellular, and molecular characteristics of HCC and may have clinical implications for precise therapeutic strategies and facilitate the investigation of immune mechanisms in HCC.
肝细胞癌(HCC)的异质性与肿瘤微环境中的免疫细胞浸润和基因畸变有关。本研究旨在根据基因和免疫特征确定HCC的新型分子分型,以实现对该疾病的精准临床管理。我们进行了一致性聚类,将424例患者分为不同的免疫亚组,并在两个包含921例患者的独立队列中评估了其可重复性和有效性。通过多维生物信息学方法研究了分子分型与分子、细胞及临床特征之间的关联。此外,我们基于图结构学习进行降维,以描绘免疫图谱,揭示分子分型中免疫和基因系统之间的相互关系。我们发现并验证了HCC患者可分为5个免疫亚组(IS1 - 5)和7个基因模块,它们具有显著不同的分子、细胞及临床特征。IS5预后最差,免疫特征富集程度最低,被认为是免疫冷型。IS4总生存期最长,免疫活性高且具有抗肿瘤发生作用,被定义为免疫热型和抗肿瘤发生型。此外,免疫图谱分析进一步揭示了每个IS内显著的组内异质性,且每个IS都代表了不同的临床、细胞和分子特征。我们的研究提供了具有不同临床、细胞和分子特征的5个HCC免疫亚组,可能对精准治疗策略具有临床意义,并有助于研究HCC的免疫机制。